Navigation Links
Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
Date:12/6/2010

ence of transmission of HBV, HCV, or HIV, and no clinically relevant anti-C1 inhibitor antibodies developed

In a poster entitled, 'Open-Label Use of Nanofiltered C1 Esterase Inhibitor (human) (nf-C1 INH) for the Prophylaxis of Attacks of Hereditary Angioedema (HAE) in Pediatric Subjects,' Dr. Colin Broom M.D., ViroPharma Incorporated, Exton, PA, presented new open label results of Cinryze in preventing HAE attacks in 23 pediatric patients with HAE.  Data from this study included the following:

  • Cinryze reduced the frequency of HAE attacks from a median of 3.0 attacks per month at baseline to 0.39 attacks per month during Cinryze prophylaxis
  • In children, prophylactic doses of 1000 U of Cinryze every 3 to 7 days resulted in increases in antigenic and functional C1-INH levels comparable to those seen in adults; increases in functional C1-INH activity were maintained over time
  • There were no severe hypersensitivity reactions related to Cinryze; no discontinuations from study due to adverse events; no detectable anti-C1 INH antibodies; and no evidence of transmission of HBV, HCV, or HIV;
  • Adverse events considered to be possibly, probably, or definitely related to Cinryze were headache, nausea, and infusion site erythema, none of which were considered severe.

In addition, the WAO has joined with The American College of Allergy, Asthma and Immunology (ACAAI) and the American Gastroenterological Association (AGA) Institute in an innovative  initiative called "HAE:  Learn About It, Talk About It."  The peer-driven campaign is designed to foster communication between physicians on the front lines of the diagnosis and management of HAE. The addition of WAO as a "Learn About It, Talk About It" partner expands the program to a global audience. The program will be highlighted in booth 13 at the WAO meeting.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
2. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
3. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
4. Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
5. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
6. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
7. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
8. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
9. Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
10. VIDEO from Merck and Co., Inc available on thenewsmarket.com: In Phase III Study Mercks Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD
11. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) ... Market 2015-2019" report to their offering. ... at a CAGR of 7.07% over the period 2014-2019 ... into two segments: Equipment and Consumables. This report covers ... Global Biobanking market for the period 2015-2019. ...
(Date:4/24/2015)... , April 24, 2015  Novartis Pharmaceuticals Corporation (NPC) has ... year in a row on the annual DiversityInc Top 50 ... 2015 Top 50 Companies for Diversity on April 23 at ... . NPC also ranked second on the DiversityInc Top 10 ... Companies for Employee Resource Groups list. ...
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
Breaking Medicine Technology:Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Lannett Expands Revolving Credit Facility To $120 Million 2
(Date:4/26/2015)... 26, 2015 The grand celebration got off ... Deb Dettor, CCAR’s Managing Director. Deb then introduced Sandy Valentine, ... not in attendance because of his Walk for Recovery ... was able to express his gratitude to the volunteers via ... their dedication to carrying out CCAR’s mission. Volunteer Manager ...
(Date:4/25/2015)... April 25, 2015 In observance of ... join The Million Nets Pledge, a two-year pledge by ... protect refugee families with one million bednets by 2016. ... work with UN partners to protect children, refugees, and ... , “There has been a large surge in ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 By definition, a ... data for the enterprise relying on their judgement and expertise ... But according to an article published in National ... times actually be doing a disservice to their responsibilities by ... dotted and t’s are crossed when it comes to company ...
(Date:4/25/2015)... York New York (PRWEB) April 25, 2015 ... that Dr. Jerry Blaivas has been chosen by the New ... for his contributions to medicine in the field of Urology. ... the best in his speciality, Genito-Urinary diseases. He was ... specifically in the field of urology. Not only did ...
(Date:4/24/2015)... NY (PRWEB) April 24, 2015 Constellations ... living residence in Westchester County. Just 35 miles from ... transition individuals back into everyday life while recovering from ... May 7, 2015, will allow therapists, doctors and treatment ... and learn more about the opportunities offered by Constellations ...
Breaking Medicine News(10 mins):Health News:The Connecticut Community for Addiction Recovery (CCAR) honors its volunteers during National Volunteer Recognition Week. 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3
... arrest who received intensive care can expect long-term quality ... system. Research published today in BioMed Central,s open access ... show that the allocation of resources to the treatment ... the treatment of other intensive care patient groups. , ...
... ... Research, Project Made Possible ... to Advancing Breakthrough Spinal Cord Discoveries, WASHINGTON, July 17 The ... the,world,s first genome-wide map of the mouse spinal cord. Researchers can,immediately access ...
... Certification Commission for Healthcare Information Technology (CCHIT®) today ... Certified®, and meets the Commission's ambulatory electronic health ... products with the CCHIT Certified seal, physicians and ... an EHR product, allowing them to focus their ...
... First Mobile Medical Service for Access to Qualified Health ... ... HTH Worldwide, a global health and,safety services company, today introduced ... access to HTH Worldwide,s databases of global health and safety,information when ...
... Pa., July 17 Universal,Health Services, Inc. (NYSE: ... to pay a cash dividend of $0.08 per share ... September 2, 2008., Universal Health Services, Inc. is ... subsidiaries, acute care and behavioral,health hospitals, and ambulatory centers ...
... disaster season continues with the response to California,wildfires, ... Fire Protection today reported 80 active,wildfires still burning in ... 17 shelters since early June to help those who ... relief operation has served more than 21,000 meals and,snacks, ...
Cached Medicine News:Health News:Heart attack not a death sentence 2Health News:Video: Allen Institute for Brain Science Unveils World's First Genome-Wide Spinal Cord Atlas 2Health News:Video: Allen Institute for Brain Science Unveils World's First Genome-Wide Spinal Cord Atlas 3Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 3Health News:HTH Worldwide Introduces mPassport(sm), Mobile Health and Safety 2Health News:HTH Worldwide Introduces mPassport(sm), Mobile Health and Safety 3Health News:As Fires Burn, Red Cross Brings Relief to Weary California 2Health News:As Fires Burn, Red Cross Brings Relief to Weary California 3
Cannulated Interference Screws...
Cannulated Interference Screws...
... CoEase is designed to provide excellent ... the unique advantage of being closer to ... cohesives. This allows CoEase to maintain ... the best of both worlds for superb ...
Finally, a camera that sees the way you do!,Combined with the MicroLux DVR (Digital Video Recorder), the MicroLux Headlight Camera System gives you an entirely new way to visualize, edit, share and...
Medicine Products: